Class of Stock [Axis] Series B-1 Convertible and Redeemable Preferred Stock [Member] Series B-2 Convertible and Redeemable Preferred Stock [Member] Series C Convertible and Redeemable Preferred Stock [Member] Series E-1 Convertible and Redeemable Preferred Stock [Member] Series F-1 Convertible and Redeemable Preferred Stock [Member] Series B Convertible and Redeemable Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] AOCI Attributable to Parent [Member] Retained Earnings [Member] Product and Service [Axis] Phexxi [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Customer [Axis] Three Largest Customers Combined [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Accounts Receivable [Member] Four Largest Customers Combined [Member] Long-Lived Tangible Asset [Axis] Building and Building Improvements [Member] Credit Facility [Axis] Letter of Credit [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Title of Individual [Axis] Employees and Nonemployee Consultants [Member] Financial Instrument Performance Status [Axis] Performance Criterion Probable [Member] Vesting [Axis] Service Criterion Complete [Member] Service Criterion Not Complete [Member] Performance Criterion Not Probable [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Warrant [Member] Series E One Shares [Member] Series F One Shares [Member] Rights [Member] Convertible Debt Securities [Member] Convertible Debt [Member] Balance Sheet Location [Axis] Trade Accounts Receivable [Member] Other Current Liabilities [Member] Debt Instrument [Axis] Baker Bros. Notes [Member] Long-Term Debt, Type [Axis] Convertible Notes Payable [Member] Baker Second Closing Notes [Member] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period Two [Member] Debt Instrument, Redemption, Period One [Member] Debt Instrument, Redemption, Period Three [Member] Class of Warrant or Right [Axis] June 2022 Baker Warrants [Member] Second Baker Amendment [Member] Baker Warrants [Member] Third Baker Amendment [Member] Secured Creditor Forbearance Agreement [Member] Old Baker Notes [Member] Short-term Convertible Notes [Member] Adjuvant Notes [Member] 5.0% Senior Subordinated Notes Due 2025 Issued January 2022 [Member] Unsecured Debt [Member] January 2022 Warrants [Member] 5.0% Senior Subordinated Notes Due 2025 Issued March 2022 [Member] March 2022 Warrants [Member] January and March 2022 Notes [Member] January and March 2022 Notes [Member] January and March 2022 Notes and Warrants [Member] Issuance [Member] January and March 2022 Warrants [Member] May 2022 Notes [Member] 5.0% Senior Subordinated Notes [Member] May 2022 Warrants [Member] 8.0% Senior Subordinated Notes Due 2025 Issued December 2022 [Member] Prior To September 8, 2024 [Member] Baker Notes [Member] September 9, 2024 - September 8, 2025 [Member] September 9, 2025 - September 8, 2026 [Member] September 9, 2026 - September 8, 2027 [Member] September 9, 2027 - September 8, 2028 [Member] December 2022 Notes [Member] February 2023 Notes [Member] March 2023 Notes [Member] March Two 2023 Notes [Member] April 2023 Notes [Member] July 2023 Notes [Member] August 2023 Notes [Member] September 2023 Notes [Member] Counterparty Name [Axis] Placement Agent [Member] December Two Thousand Twenty Two To September Two Thousand Twenty Three [Member] Series A Preferred Stock [Member] Series B Preferred Stock [Member] Asset Class [Axis] Insurance [Member] Research and Development Related Costs [Member] Other Current Assets [Member] Equipment [Member] Computer Equipment and Software [Member] Furniture and Fixtures [Member] Leasehold Improvements [Member] Construction in Progress [Member] Short-Term Debt, Type [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Money Market Funds [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Measurement Basis [Axis] Reported Value Measurement [Member] Estimate of Fair Value Measurement [Member] May 2022 Notes [Member] Liability Class [Axis] Derivative Financial Instruments, Liabilities [Member] Derivative Instrument [Axis] April and June 2022 Baker Warrants [Member] May 2022 Public Offering Warrants [Member] June 2022 Baker Warrants [Member] December 2022 Warrants [Member] Long-Term Debt [Member] Bakers First Closing Note [Member] Bakers Second Closing Notes [Member] Bakers Notes Fourth Amendment [Member] Baker Notes Assigned To Aditxt Notes [Member] Total Offerings [Member] 5.0% Senior Subordinated Notes Due 2025 Issued May 2022 [Member] December Notes [Member] Derivative Liability Convertible Preferred Stock [Member] February and March 2023 Notes [Member] Convertible Preferred Stock Conversion Feature [Member] Derivative Liabilities Previously Classifiedas Equity Instruments [Member] May 2022 Warrants [Member] May 2022 Public Offering Pre-Funded Warrants [Member] Purchase Rights [Member] Measurement Input Type [Axis] Measurement Input Royalty Rate [Member] Measurement Input, Discount Rate [Member] Senior Subordinated Notes [Member] Convertible and Redeemable Preferred Stock [Member] Lease Contractual Term [Axis] Lease Contract Term One [Member] Vehicles [Member] Lease Contract Term [Member] Financial Instrument [Axis] Securities Deposit [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Rush License Agreement [Member] Income Statement Location [Axis] Research and Development Expense [Member] Selling and Marketing Expense [Member] General and Administrative Expense [Member] Baker Bros Purchase Agreement [Member] Securities Purchase Agreement [Member] Exchange Agreement [Member] Sale of Stock [Axis] May 2022 Public Offering [Member] Prefunded Warrants [Member] Second May 2022 Public Offering Warrants [Member] Security Purchase Agreement [Member] Series F-1 Common Stock [Member] Series B-1 Convertible Preferred Stock [Member] Registered Direct Offering [Member] Series B-2 Convertible Preferred Stock [Member] Series C Convertible Preferred Stock [Member] Series E-1 Convertible Preferred Stock [Member] Series D Non-Convertible Preferred Stock [Member] Public Offering [Member] Common Stock Purchase Agreement [Member] Seven Knots LLC [Member] Stock Purchase Agreement [Member] Unregistered Shares [Member] A 360 Media LLC Agreement For Services [Member] Adjuvant and May 2022 Notes [Member] Exchange Agreements [Member] Common Warrants [Member] Plan Name [Axis] Employee Stock Purchase Plan 2019 [Member] Amended and Restated 2014 Plan [Member] Inducement Plan [Member] 2012 Equity Incentive Plan [Member] Share-Based Payment Arrangement, Tranche One [Member] Share-Based Payment Arrangement, Tranche Two [Member] Award Type [Axis] Restricted Stock [Member] Employee Stock [Member] Income Tax Authority [Axis] Domestic Tax Authority [Member] State and Local Jurisdiction [Member] Revision of Prior Period [Axis] Revision of Prior Period, Reclassification, Adjustment [Member] Series F One Preferred Stock [Member] Business Acquisition [Axis] Merger Agreement [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Name Auditor Location Statement of Financial Position [Abstract] Assets Current assets: Cash and cash equivalents Restricted cash Trade accounts receivable, net Inventories Prepaid and other current assets Total current assets Property and equipment, net Operating lease right-of-use assets Other noncurrent assets Total assets Liabilities, convertible preferred stock and stockholders’ deficit Current liabilities: Accounts payable Convertible notes payable carried at fair value (Note 4) Convertible notes payable - Adjuvant (Note 4) Accrued expenses Accrued compensation Operating lease liabilities - current Derivative liabilities Other current liabilities Total current liabilities Operating lease liabilities - non-current Total liabilities Commitments and contingencies (Note 7) Convertible and redeemable preferred stock, $0.0001 par value, Senior to common stock Series B-1, B-2, C, E-1, and F-1 convertible preferred stock, 5,000, 5,000, 1,700, 2,300, and 95,000 shares authorized; 1,874 shares of E-1 and 22,280 shares of F-1 issued and outstanding at December 31, 2023; ID="xdx_902_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_do_c20221231_z9td8XwZCcQ3" TITLE="Temporary equity, shares outstanding" Stockholders’ deficit: Preferred stock, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding at December 31, 2023 or 2022 Common Stock, $0.0001 par value; 3,000,000,000 shares authorized; 20,007,799 and 984,786 shares issued and outstanding as of December 31, 2023 and 2022, respectively Additional paid-in capital Accumulated other comprehensive income (loss) Accumulated deficit Total stockholders’ deficit Total liabilities, convertible and redeemable preferred stock and stockholders’ deficit Statement [Table] Statement [Line Items] Convertible preferred stock, par value Temporary equity, shares authorized Temporary equity, shares issued Temporary equity, shares outstanding Preferred stock par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Product sales, net Operating expenses: Cost of goods sold Research and development Selling and marketing General and administrative Total operating expenses Loss from operations Other income (expense): Interest income Other expense, net Loss on issuance of financial instruments Gain (loss) on debt extinguishment Change in fair value of financial instruments Total other income, net Income (loss) before income tax Income tax expense Net income (loss) Deemed dividends Net income (loss) attributable to common stockholders Net income (loss) per share attributable to common stockholders: Basic (Note 2) Diluted (Note 2) Weighted-average shares used to compute net income (loss) per share: Basic Diluted Net income (loss) Other comprehensive income: Change in fair value of financial instruments attributed to credit risk change Reclassification adjustment related to debt extinguishment Comprehensive income (loss) Balance, value Temporary equity, Balance, shares Common stock, Balance, shares Issuance of common stock - Stock Purchase Agreement (Note 8) Issuance of common stock - Stock Purchase Agreement (Note 8), shares Issuance of common stock - May 2022 Public Offering (see Note 8) Issuance of common stock - May 2022 Public Offering (see Note 8), shares Issuance of common stock upon cash exercise of warrants Issuance of common stock upon cash exercise of warrants, shares Issuance of common stock - ESPP Issuance of common stock - ESPP, shares Issuance of common stock - a360 Media Issuance of common stock - a360 Media, shares Issuance of common stock upon noncash exercise of purchase rights Issuance of common stock upon noncash exercise of purchase rights, shares Conversion of series B-2 convertible preferred stock Temporary equity, Conversion of series B-2 convertible preferred stock, shares Conversion of series B-2 convertible preferred stock, shares Exchange of series B-2 convertible preferred stock (see Note 8) Exchange of series B-2 convertible preferred stock (see Note 8), shares Convertible preferred stock deemed dividends Restricted stock awards issued Restricted stock awards issued, shares Restricted stock awards cancelled Restricted stock awards cancelled, shares May 2022 exchange transaction Temporary equity, May 2022 exchange transaction, shares May 2022 exchange transaction, shares Cash repurchase of fractional common stock after the reverse stock split Cash repurchase of fractional common stock after the reverse stock split, shares Issuance of December 2022 Notes Change in fair value of financial instruments attributed to credit risk change (see Note 4) Modification of Baker Warrants (see Note 4) Stock-based compensation Issuance of SSNs (See Note 4) Issuance of common stock upon conversion of notes Issuance of common stock upon conversion of notes, shares Issuance of convertible and redeemable preferred stock upon exchange of notes with existing equity holders Issuance of convertible and redeemable preferred stock upon exchange of notes with existing equity holders, shares Issuance of convertible and redeemable preferred stock upon exchange of partial purchase rights value and warrants (see Note 8) Issuance of convertible and redeemable preferred stock upon exchange of partial purchase rights value and warrants, shares Adjustment related to reverse stock split (fractional shares) Adjustment related to downround feature for financial instruments Reverse of AOCI upon Baker’s 4th Amendment Series E-1 Shares dividends Series E-1 Shares dividends, shares Balance Temporary equity, Balance, shares Common stock, Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net income (loss) to net cash and restricted cash used in operating activities: Loss on issuance of financial instruments Gain on debt extinguishment Change in fair value of financial instruments Financial instrument modification expense Stock-based compensation Depreciation Noncash interest expenses Noncash right-of-use amortization Noncash inventory reserve for excess & obsolescence Net gain on lease termination Noncash instrument exchange expense Loss on disposal and write-down of property and equipment Gain on accounts payable settlements Changes in operating assets and liabilities: Trade accounts receivable Inventories Prepaid and other assets Accounts payable Accrued expenses and other liabilities Accrued compensation Lease liabilities Net cash and restricted cash used in operating activities Purchases of property and equipment Net cash and restricted cash used in investing activities Cash flows from financing activities: Proceeds from issuance of common stock - exercise of warrants Proceeds from issuance of common stock and warrants, net of offering costs Proceeds from issuance of common stock – Public Offering, net of commissions – ATM transactions Proceeds from issuance of common stock- ESPP and exercise of stock options Borrowings under term notes Payments under term notes Cash repurchase of fractional common stock after reverse stock split Cash paid for offering costs Net cash and restricted cash provided by financing activities Net change in cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Supplemental cash flow information: Cash paid for interest Cash paid for taxes Supplemental disclosure of noncash investing and financing activities: Exchange of convertible notes to Series E-1 Shares Exchange of warrants and partial purchase rights value to Series F-1 Shares Issuance of common stock upon exercise of purchase rights Series E-1 shares dividends Right-of-use assets obtained in exchange for operating lease liabilities Purchases of property and equipment included in accounts payable and accrued expenses Conversion of series B-2 and B-1 convertible preferred stock to common stock Exchange of series B-2 convertible preferred stock to series C convertible preferred stock Issuance of common stock for prepaid advertising Exchange of Adjuvant Notes for Purchase Rights Exchange of term notes for Purchase Rights Accounting Policies [Abstract] Description of Business and Basis of Presentation Summary of Significant Accounting Policies Revenue from Contract with Customer [Abstract] Revenue Debt Disclosure [Abstract] Debt Organization, Consolidation and Presentation of Financial Statements [Abstract] Balance Sheet Details Fair Value Disclosures [Abstract] Fair Value of Financial Instruments Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Equity [Abstract] Stockholders’ Deficit Share-Based Payment Arrangement [Abstract] Stock-based Compensation Retirement Benefits [Abstract] Employee Benefits Income Tax Disclosure [Abstract] Income Taxes Accounting Changes and Error Corrections [Abstract] Out of Period Adjustments Subsequent Events [Abstract] Subsequent Events Use of Estimates Segment Reporting Concentrations of Credit Risk Cash, Cash Equivalents and Restricted Cash Trade Accounts Receivable and Allowance Fair Value of Financial Instruments Inventories Property and Equipment Impairment of Long-lived Assets Clinical Trial Accruals Fair Value of Warrants Leases Revenue Research and Development Advertising Patent Expenses Stock-based Compensation Fair Value of Stock Options Performance-based Awards Income Taxes Net Income (Loss) per Share Recently Adopted Accounting Pronouncements Recently Issued Accounting Pronouncements Schedule of Reconciliation of Cash and Restricted Cash Schedule of Inventories Schedule of Stock-Based Awards Expensing Policies for Employees and Non-Employees Schedule of Potentially Dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share Schedule of Weighed Average Common Shares Outstanding for Diluted Net Loss Per Share Schedule of Repurchase Price Reduction Schedule of Interest Expense Schedule of SSNs and Warrants Schedule of Prepaid and Other Current Assets Schedule of Property and Equipment Net Schedule of Other Noncurrent Assets Schedule of Accrued Expenses Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Schedule of Fair Value of Financial Assets Schedule of Fair Value of Financial Liabilities Schedule of Change in Fair Value of Level 3 Financial Liabilities Schedule of Lease Cost Schedule of Lease Term and Discount Rate Schedule of Operating Lease Maturities Schedule of Supplement Cash Outflows in Operating Leases Schedule of Warrants Summary of Common Stock Reserved for Future Issuance Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Schedule of Stock-based Compensation Expense Related to Stock Options Schedule of Stock Option Activity Schedule of Weighted Average Assumptions Schedule of Restricted Stock Awards Schedule of Consolidated Pretax Loss from Continuing Operations Schedule of Income Tax Provision from Continuing Operations Schedule of Effective Tax Rate on Loss from Continuing Operations and the Statutory Tax Rate Schedule of Net Deferred Tax Assets arising from its Taxable Subsidiaries Schedule of Activity related to the Gross Unrecognized Tax Benefits Schedule of Product Information [Table] Product Information [Line Items] Revenue from product sales Reverse stock split description Working capital deficit Accumulated deficit Share price Debt instrument, restrictive covenants, cumulative net sales requirement Restricted cash included in other noncurrent assets Total cash, cash equivalents and restricted cash presented in the consolidated statements of cash flows Raw Materials Work in process Finished Goods Total Inventory, net of reserves Additional inventory write down Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] Performance criterion is probable and not probable description Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total Net income attributable to common stockholders Change in fair value of purchase rights Noncash interest expense on convertible notes, net of tax Net income attributable to common stockholders Weighted average shares used to compute net income attributable to common stockholder, basic Pro forma adjustments to reflect the assumed conversion of Series F-1 Shares Weighted average shares used to compute net loss attributable to common stockholder, diluted Net income per share attributable to common stockholders, diluted Concentration risk, percentage Letters of credit Proceeds from issuancde of notes Notice of default increase decrease in restricted cash Trade accounts receivable and allowance Useful life Operating lease liability Down round feature, decrease in net income (loss) to common shareholder, amount Payment term Product revenue variable consideration liability current Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Debt instrument, repurchase amount Coupon interest Amortization of issuance costs Total (4) Principal at issuance Gross proceeds before issuance costs Warrants at issued (common stock) Preferred Shares Maturity Date Conversion price Number of shares to purchase capital stock Warrants Warrants Debt instrument, face amount Class of warrant or right, number of securities called by warrants or rights Warrant exercise price per share [custom:ClassOfWarrantOrRightVestingTerm] Debt instrument, term Debt instrument, term with no prepayment Debt instrument conversion rate Debt instrument interest rate effective percent Interest expense Written notice period Debt instrument, redemption price, percentage Debt instrument, benchmark price per share Debt instrument conversion price per share Conversion price as a percentage of lowest stock price Proceeds from issuance of sale of equity Debt covenant, cumulative net sales requirement Exercise price Conversion price threshold percentage Proceeds from issuance of common stock Debt instrument indebtedness amount Debt instrument periodic payment Cumulative net sales Accrued interest percentage Interest revenue expenses net Debt and interest payment description Notes payable fair value Accumulated other comprehensive income Short-term convertible notes payable Gains losses on extinguishment of debt Revalued amount extinguishment of debt amount Accrued interest Beneficial ownership limitation percentage Beneficial ownership limitation percentage Common stock, par value (in usd per share) Debt instrument weighted average period Debt instrument weighted average price per share Debt instrument convertible exchange percentage Debt Conversion, Converted Instrument, Amount Debt conversion converted instrument amount Restricted cash Convertible debt Convertible debt, current principal amount Convertible debt, current, accrued interest Debt Conversion, converted instrument, shares issued Debt instrument interest rate stated percent Debt instrument, unamortized discount Warrants and rights outstanding, term Notes interest rate increased percentage Redemption premium percentage Notes payable Warrants rights and outstanding Gain (loss) on issuance Gain (loss) in fair value of financial instrument Exchange agreement, number of B2 convertible shares to be redeemed Exchange agreement, number of convertible shares to be redeemed Exchange agreement number of common shares to be redeemed Exchange agreement number of common shares to be issued to investors Debt instrument, redemption price, percentage Debt instrument, underwritten public offering threshold amount Repayment of debt Trading period suspension Debt default interest rate Debt default redemption percentage Warrants to purchase up Warrants outstanding Warrants outstanding Impairment Effects on Earnings Per Share [Table] Impairment Effects on Earnings Per Share [Line Items] Total Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment gross Useful Life Less: accumulated depreciation Total, net Restricted cash included in noncurrent assets Inventories, long-term Prepaid directors & officers’ insurance Other Total Clinical trial related costs Accrued royalty Other Total Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets Principal Amount Unamortized Issuance Costs Accrued Interest Net carrying amount Fair value amount Redemption Amount Amount Exchanged Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Interest paid in kind Percent reduction in principal and interest Notes reduction Reduction in interest Exercise price threshold for out of the money warrants Balance at December 31, 2021 Balance at issuance Payments Extinguishment/conversion Change in fair value presented in the consolidated statements of operations Change in fair value presented in the Consolidated Statements of Operations Balance at December 31, 2022 Payments May 2022 exchange transaction Exercises Reclassified to equity Conversion of series B-2 convertible preferred stock Loss on re-valuation of derivative liabilities presented in the consolidated statement of operations. Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Revenue from cumulative net sales Debt instrument, measurement input Change in fair value of financial instruments Retained Earnings (Accumulated Deficit) Loss Contingencies [Table] Loss Contingencies [Line Items] Operating lease expense Weighted Average Remaining Lease Term (in years) Weighted Average Discount Rate Year ending December 31, 2024 Year ending December 31, 2025 Year ending December 31, 2026 Total lease payments Less imputed interest Total Operating cash outflows in operating leases Lessee, Operating Lease, Term of Contract Number of leased vehicles Lessee operating lease extended lease term Square footage Security deposit Operating lease liabilities Gain on termination of lease Company area (in square feet) Lease expenses Lease percentage Sublease gross income Purchase obligation, purchases during the period Accounts payable, trade Percentage of accounts payable trade Royalty cost Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Class of warrant or right outstanding Exercise price Warrants exercise period Common stock reserved upon exercise of stock options outstanding Common stock reserved upon exercise of common stock warrants Number of shares available for grant Common stock reserved for the exercise of purchase rights Common stock reserved for conversion of convertible notes Number of shares available for grant Common stock reserved for the conversion of Series F-1 Shares Common stock capital shares reserved for future issuance Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] Warrants term Debt instrument convertible threshold percentage of stock price trigger minimum Debt instrument convertible threshold percentage of stock price trigger maximum Class of warrant or right, number of securities called by each warrant or right Proceeds from Warrant Exercises Common Stock, Par or Stated Value Per Share Benefical ownership limitation Benefical ownership limitation Exercise price Warrants to purchase up Conversion of stock, shares issued Preferred stock, par value Sale of stock number of shares issued in transaction Sale of stock price per share Conversion of stock Stock issued during convertible securities Conversion price per share Fixed conversion price Temporary equity shares exchange of convertible securities Temporary equity, par value Temporary equity stated value per share Exchange agreement, aggregate principal amount redeemed Exchange agreement, number of warrants to be issued Temporary Equity, Shares Outstanding Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock Dividend Preferred stock, convertible shares issuable Preferred stock voting right power percentage Proceeds from Issuance Initial Public Offering Payments for Repurchase of Initial Public Offering Stock sale agreement, authorized amount Commitment fee Service agreement, cash option Issued for services Shares issued price per share Aggregate purchase rights Debt Instrument, Convertible, Number of Equity Instruments [custom:LossOnIssuanceOfFinancialInstruments] Common stock capital share reserved for future issuance Purchase rights to purchase common stock Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Total Options, Outstanding Weighted Average Exercise Price, Outstanding Weighted Average Remaining Contractual Term, Outstanding Aggregate Intrinsic Value, Outstanding Weighted Average Exercise Price, Granted Weighted Average Exercise Price, Granted Aggregate Intrinsic Value, Granted Weighted Average Exercise Price, Exercised Weighted Average Exercise Price, Exercised Aggregate Intrinsic Value, Exercised Weighted Average Exercise Price, Forfeited Weighted Average Exercise Price, Forfeited Aggregate Intrinsic Value, Forfeited Options, Outstanding Weighted Average Exercise Price, Outstanding Aggregate Intrinsic Value, Outstanding Options expected to vest Weighted Average Exercise Price, Options expected to vest Weighted Average Remaining Contractual Term, Options expected to vest Aggregate Intrinsic Value, Options expected to vest Options vested and exercisable Weighted Average Exercise Price, Options vested and exercisable Weighted Average Remaining Contractual Term, Options vested and exercisable Aggregate Intrinsic Value, Options vested and exercisable Weighted average grant date fair value per share of options granted during the period (in usd per share) Cash received from options exercised during the period Intrinsic value of options exercised during the period Expected volatility Risk-free interest rate Expected dividend yield Expected term (years) Restricted Stock Awards, Unvested Weighted Average Fair Value Per Share, Unvested Restricted Stock Awards, Granted Weighted Average Fair Value Per Share, Granted Restricted Stock Awards, Forfeited Weighted Average Fair Value Per Share, Forfeited Restricted Stock Awards, Released Weighted Average Fair Value Per Share, Released Restricted Stock Awards, Unvested Weighted Average Fair Value Per Share, Unvested Management [Member] Share-based payment award, expiration period Share-based payment award, vesting period Share-based payment award, vesting percentage Percentage of common stock issued and outstanding Share-based payment award, number of shares authorized Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Performance-based shares Stock-based compensation expense Common stock reserved for future issuance Authorized issuance of common stock Employee stock purchase plan percentage of employees salary minimum Employee stock purchase plan percentage of employees salary maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Fair market value Stock Issued During Period, Shares, Employee Stock Purchase Plans Noncash stock-based compensation expense Defined contribution plan period participation Defined contribution percent Defined contribution amount US Total US State Total current tax provision Total deferred tax provision Total Statutory rate State income tax, net of federal benefit Nondeductible expenses Equity-based expenses Change in fair value of purchase rights Change in fair value of financial instruments Return to provision Tax credits Uncertain tax positions Change in valuation allowance Effective tax rate Deferred tax assets: Net loss carryforwards Fixed assets and intangibles Research and development capitalization Research and development credits Stock-based compensation Other Total deferred tax assets Deferred tax liabilities Lease assets Fixed assets Other Less: valuation allowance Net deferred tax assets Balance at the beginning of the year Adjustments related to prior year tax positions Increases related to current year tax positions Decreases due to statute of limitation expiration Balance at end of year Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards Tax Credit Carryforward, Amount Accounting Standards Update and Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Additional paid in capital Accumulated other comprehensive income Subsequent Event [Table] Subsequent Event [Line Items] Stock Repurchased During Period, Shares Preferred Stock, Par or Stated Value Per Share Payments for Repurchase of Preferred Stock and Preference Stock Phexxi [Member] Convertible notes payable current adjuvant. Working capital surplus deficit. Series B-1 Convertible and Redeemable Preferred Stock [Member] Series B-2 Convertible and Redeemable Preferred Stock [Member] Series C Convertible and Redeemable Preferred Stock [Member] Series E-1 Convertible and Redeemable Preferred Stock [Member] Milestone method revenue recognized. Three Largest Customers Combined [Member] Notice of default increase decrease in restricted cash. Gain loss on issuance of financial instruments Temporary equity, convertible preferred stock deemed dividends. Series B Convertible and Redeemable Preferred Stock [Member] Clinical Trial Accruals Policy [Policy Text Block] Fair Value of Warrants [Policy Text Block] Stock issued during period value common stock upon cash exercise of warrants. Exchange of series B2 convertible preferred stock value. Stock issued during period value exchange transaction. Lease Contract Term One [Member] Lease Contract Term [Member] Number of leased vehicles. Securities Deposit [Member] Lessee operating lease extended lease term. Office square footage. Lessee operating sublease rentable area. Temporary equity shares exchange of convertible securities. Temporary equity shares exchange transaction. Stock issued during period shares common stock upon cash exercise of warrants. Patent Expense Policy [Policy Text Block] Schedule Of Lease Term And Discount Rate [Table Text Block] Fair Value Of Stock Options [Policy Text Block] Series F-1 Convertible and Redeemable Preferred Stock [Member] Accounts payable trade 90 days past due or more percent. Rush License Agreement [Member] Employees and Nonemployee Consultants [Member] Baker Bros Purchase Agreement [Member] Baker Warrants [Member] Performance Criterion Probable [Member] Service Criterion Complete [Member] Service Criterion Not Complete [Member] Securities Purchase Agreement [Member] Performance Criterion Not Probable [Member] Exchange Agreement [Member] May 2022 Public Offering [Member] Prefunded Warrants [Member] June 2022 Baker Warrants [Member] Security Purchase Agreement [Member] Purchase rights change in fair value. Common stock reserved up on exercise of common stock warrants. Weighted average shares used to compute net loss attributable to common stockholder basic. Series F-1 Common Stock [Member] Performance Based Awards [Policy Text Block] Recently Issued Accounting Pronouncements [Policy Text Block] Common Warrants [Member] Contract with customer payment term. Product revenue variable consideration liability current. Baker Bros. Notes [Member] Baker First Closing Notes [Member] Warrants exercise period, description. Purchase agreement maximum amount of securities purchasable under agreement. Baker Second Closing Notes [Member] Class of warrant or right vesting term. Debt instrument term with no prepayment. Debt instrument, convertible, written notice period. Debt instrument, convertible, conversion price, percentage of lowest stock price. Reverse of accumulated other comprehensive income loss. June 2022 Baker Warrants [Member] Financial Instrument Modification Expense. Financial Instrument Expense, Noncash. Increase decrease in operating lease liabilities. Series B-1 Convertible Preferred Stock [Member] Registered Direct Offering [Member] Second Baker Amendment [Member] Series B-2 Convertible Preferred Stock [Member] Series C Convertible Preferred Stock [Member] Temporary equity stated value per share. Proceeds from issuance of common stock and warrants, net of offering costs. Third Baker Amendment [Member] Exchange agreement aggregate principal amount redeemed. Exchange agreement number of warrants to be issued. Secured Creditor Forbearance Agreement [Member] Cumulative net sales. Accrued interest agreement percentage. Series E-1 Convertible Preferred Stock [Member] Debt instrument redemption premium in event of default. Prior To September 8, 2024 [Member] Baker Notes [Member] September 9, 2024 - September 8, 2025 [Member] September 9, 2025 - September 8, 2026 [Member] September 9, 2026 - September 8, 2027 [Member] September 9, 2027 - September 8, 2028 [Member] Old Baker Notes [Member] Accumulated other comprehensive income debt. Revalued amount extinguishment of debt amount. Adjuvant Notes [Member] Temporary equity value exchange of convertible securities. Exchange of convertible notes to series e-1 convertible preferred stock. Exchange of Adjuvant Notes for Purchase Rights. Exchange of term notes to purchase rights. Debt instrument convertible weighted average price per share. Debt instrument convertible weighted average period. Debt instrument convertible exchange percentage. Debt conversion converted instrument amount. Convertible debt noncurrent principal amount. Convertible debt noncurrent accrued interest. Computer Equipment and Software [Member] 5.0% Senior Subordinated Notes Due 2025 Issued January 2022 [Member] January 2022 Warrants [Member] Series D Non-Convertible Preferred Stock [Member] Preferred stock voting rights power percentage. Public Offering [Member] May 2022 Public Offering Warrants [Member] Accrued clinical studies current. 5.0% Senior Subordinated Notes Due 2025 Issued March 2022 [Member] May 2022 Public Offering Pre-Funded Warrants [Member] March 2022 Warrants [Member] January and March 2022 Notes [Member] Debt instrument interest rate in event of default. Stock sale agreement authorized amount. Stock issued during period shares issued for commitment fee. Service agreement cash option. Unregistered Shares [Member] Common stock capital share reserved for future issuance. Issuance [Member] December 2022 Notes [Member] February 2023 Notes [Member] May 2022 Notes [Member] Exchange agreement, number of common shares to be redeemed. 5.0% Senior Subordinated Notes [Member] Exchange agreement, number of common shares to be issued to investors. Common stock reserved upon exercise of stock options outstanding. Employee Stock Purchase Plan 2019 [Member] Amended and Restated 2014 Plan [Member] Inducement Plan [Member] Debt instrument underwritten public offering threshold amount. Debt instrument covenant default trading period suspension. Debt instrument covenant default interest rate. Debt instrument covenant default redemption percentage. Insurance [Member] 2012 Equity Incentive Plan [Member] May 2022 Warrants [Member] Short-term Convertible Notes [Member] January and March 2022 Notes [Member] January and March 2022 Notes and Warrants [Member] January and March 2022 Warrants [Member] 8.0% Senior Subordinated Notes Due 2025 Issued December 2022 [Member] Share based compensation arrangement by share based payment award options percent exercisable. March 2023 Notes [Member] Share based compensation by share based payment award automatic authorized increase percentage of common stock issued and outstanding. April 2023 Notes [Member] July 2023 Notes [Member] Schedule of Senior Subordinated Notes and Warrants [Table Text Block] August 2023 Notes [Member] September 2023 Notes [Member] March Two 2023 Notes [Member] Debt instrument reduction in principal and interest percent. Defined contribution plan period required before participation. Debt instrument reduction in interest. May 2022 Notes [Member] Debt instrument, amount exchanged. April and June 2022 Baker Warrants [Member] December 2022 Warrants [Member] Bakers First Closing Note [Member] Bakers Second Closing Notes [Member] Bakers Notes Fourth Amendment [Member] Total Offerings [Member] Effective income tax rate reconciliation change in fair value of purchase rights. Effective income tax rate reconciliation change in fair value of warrants percent. Effective income tax rate reconciliation provision to return. Effective income tax rate reconciliation accrual of uncertain tax positions. Fair value measurement with unobservable inputs reconciliation recurring basis liability extinguishment. Deferred Tax Liabilites Net [Abstract] 5.0% Senior Subordinated Notes Due 2025 Issued May 2022 [Member] December Notes [Member] Derivative Liability Convertible Preferred Stock [Member] February and March 2023 Notes [Member] Fair value measurement with unobservable inputs reconciliation recurring basis liability warrant exercises. Common stock reserved for future issuance under employee stock purchase plan. Purchase Rights [Member] Share based compensation arrangement by share based payment award incremental number of shares authorized. Convertible Preferred Stock Conversion Feature [Member] May 2022 Warrants [Member] Derivative Liabilities Previously Classifiedas Equity Instruments [Member] Other. Measurement Input Royalty Rate [Member] Convertible and Redeemable Preferred Stock [Member] Share based compensation arrangement by share based payment award options granted intrinsic value. Share based compensation arrangement by share based payment award options cancelled intrinsic value. Stock issued during period value conversion of convertible preferred stock. Stock issued during period shares conversion of convertible preferred stock. Temporary equity shares conversion of convertible preferred stock. Stock issued during period shares exchange transaction. Issuance of common stock upon exercise of purchase rights. Four Largest Customers Combined [Member] Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, loss on re-valuation of derivative liabilities. Research and Development Related Costs [Member] Second May 2022 Public Offering Warrants [Member] Employee stock purchase plan maximum stock value available for purchase denominator. Temporary equity convertible and redeemable preferred stock dividends shares. Exchange Agreements [Member] Common Stock Purchase Agreement [Member] Employee stock purchase plan percentage of employees salary minimum. Employee stock purchase plan percentage of employees salary maximum. Debt instrument convertible beneficial ownership limitation minimum. Debt instrument convertible beneficial ownership limitation maximum. Debt instrument convertible threshold percentage of stock price trigger minimum. Debt instrument convertible threshold percentage of stock price trigger maximum. Exchange Agreement, Number B 2 Series Of Convertible Shares To Be Redeemed Exchange Agreement, Number Of C Series Convertible Shares To Be Redeemed Gains on extinguishment of debt. Series F One Shares [Member] Reclassification adjustment related to debt extinguishment. Change in fair value of financial instruments. Issuance of convertible and redeemable preferred stock upon exchange of notes with existing equity holders. Issuance of convertible and redeemable preferred stock shares upon exchange of notes with existing equity holders. Gain loss on accounts payable settlements. Proceeds from issuance of common stock the offering. Adjustment related to reverse stock split. Proceeds from issuance of preferred stock registered direct offering. Issuance of additional purchase rights for downround feature Series F One Preferred Stock [Member] Merger Agreement [Member] Noncash right-of-use expenses Placement Agent [Member] December Two Thousand Twenty Two To September Two Thousand Twenty Three [Member] Class of warrant or right exercise price out of the money threshold. Seven Knots LLC [Member] Stock Purchase Agreement [Member] A 360 Media LLC Agreement For Services [Member] Issuance of convertible and redeemable preferred stock upon exchange of partial purchase rights value and warrants shares. Exchange of warrants and partial purchase rights value to seriesF1 shares. Series E1 shares dividends. Series E One Shares [Member] Baker Notes Assigned To Aditxt Notes [Member] Adjuvant and May 2022 Notes [Member] Issuance of convertible and redeemable preferred stock upon exchange of partial purchase rights value and warrants. Fair value measurement with unobservable inputs reconciliation recurring basis liability debt payment. Exchange of convertible notes to Series E-1 Shares. Convertible debt current principal amount. Convertible debt current accrued interest. Additional Inventory write down. Temporary equity deemed dividends. Loss on issuance of financial instruments. Deemed dividends. Noncash right of use amortization. January and March 2022 Notes [Member] [Default Label] May 2022 Notes [Member] [Default Label] June 2022 Baker Warrants [Member] [Default Label] May 2022 Warrants [Member] [Default Label] Assets, Current Assets [Default Label] Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Costs and Expenses Operating Income (Loss) Other Nonoperating Expense Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income Tax Expense (Benefit) DeemedDividends Comprehensive Income (Loss), Net of Tax, Attributable to Parent Dividends, Preferred Stock Stock Issued During Period, Shares, Restricted Stock Award, Forfeited Stock Repurchased During Period, Value Stock Issued During Period, Value, Stock Dividend Share-Based Payment Arrangement, Noncash Expense Gain (Loss) on Disposition of Property Plant Equipment GainLossOnAccountsPayableSettlements Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Employee Related Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Long-Term Debt Payments for Repurchase of Common Stock Restricted Stock, Value, Shares Issued Net of Tax Withholdings Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Fair Value Measurement, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] Revenue from Contract with Customer [Policy Text Block] Share-Based Payment Arrangement [Policy Text Block] Income Tax, Policy [Policy Text Block] Inventory, Gross Net Income (Loss) Available to Common Stockholders, Diluted Interest Expense, Debt Restricted Cash Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed Shares, Outstanding Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Other Accrued Liabilities, Current Assets, Fair Value Disclosure Unamortized Debt Issuance Expense Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityDebtPayment Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Preferred Stock, Capital Shares Reserved for Future Issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Current Federal Tax Expense (Benefit) Current Income Tax Expense (Benefit) EffectiveIncomeTaxRateReconciliationChangeInFairValueOfPurchaseRights EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantsPercent Effective Income Tax Rate Reconciliation, Tax Credit, Percent Effective Income Tax Rate Reconciliation, Percent Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits Deferred Tax Assets, Other Deferred Tax Assets, Gross Deferred Tax Liabilities, Leasing Arrangements Deferred Tax Liabilities, Property, Plant and Equipment Deferred Tax Liabilities, Other Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance Unrecognized Tax Benefits